NMPA Approval

Compound Guaiacol Potassium Sulfonale Oral Solution

Approval Number

国药准字H65020222

Company国药集团新疆制药有限公司

Registration Date

February 11, 2022

Previous Approval Numbers

国药准字 H65020222

Drug Information

Generic Name

复方愈创木酚磺酸钾口服溶液

Dosage Form

口服溶液剂

Strength

复方

Drug Type

化学药品

Registration Date

February 11, 2022

Company Information

Applicant Company

Company Name国药集团新疆制药有限公司

Company Address

新疆乌鲁木齐市头屯河区工业园沙坪西街21号

Manufacturing Company

Company Name国药集团新疆制药有限公司

Company Address

新疆乌鲁木齐市头屯河区工业园沙坪西街21号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方愈创木酚磺酸钾口服溶液 - NMPA 批准文号 | MedPath